Nanjing Medlander Medical Technology Co.,Ltd. (SHA:688273)
44.29
+0.81 (1.86%)
At close: Mar 9, 2026
SHA:688273 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Net Income | - | 101.58 | 89.82 | 121.68 | 118.38 | Upgrade
|
| Depreciation & Amortization | - | 25.07 | 17.84 | 14.47 | 11.42 | Upgrade
|
| Other Amortization | - | 3.94 | 2.29 | 3.14 | 1.68 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0.12 | -0.23 | 0 | -0.31 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 9.94 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -5.07 | -14.54 | -7.97 | -4.77 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 0.81 | 0.45 | 2.84 | 0.55 | Upgrade
|
| Other Operating Activities | - | 8.93 | 3.71 | 8.33 | 1.75 | Upgrade
|
| Change in Accounts Receivable | - | -9.48 | 16.38 | -16.48 | 2.61 | Upgrade
|
| Change in Inventory | - | -16.13 | 16.09 | -31.03 | -18.04 | Upgrade
|
| Change in Accounts Payable | - | -1.54 | 3.37 | 23.09 | 32.14 | Upgrade
|
| Change in Other Net Operating Assets | - | -0.01 | 4.74 | 5.39 | 4.95 | Upgrade
|
| Operating Cash Flow | - | 122.51 | 136.91 | 126.67 | 148.6 | Upgrade
|
| Operating Cash Flow Growth | - | -10.52% | 8.08% | -14.75% | 13.35% | Upgrade
|
| Capital Expenditures | - | -129.71 | -75.15 | -54.26 | -14.58 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.75 | 0.57 | 0.03 | 0.36 | Upgrade
|
| Cash Acquisitions | - | -17.29 | -10.5 | - | - | Upgrade
|
| Investment in Securities | - | -347.4 | -166.58 | -40 | - | Upgrade
|
| Other Investing Activities | - | -14.42 | 14.23 | 7.93 | 5.5 | Upgrade
|
| Investing Cash Flow | - | -508.07 | -237.43 | -86.31 | -8.73 | Upgrade
|
| Short-Term Debt Issued | - | 7 | - | - | - | Upgrade
|
| Total Debt Issued | - | 7 | - | - | - | Upgrade
|
| Short-Term Debt Repaid | - | -6.73 | - | - | -7.34 | Upgrade
|
| Long-Term Debt Repaid | - | -10.89 | -4.44 | -6.96 | -3.06 | Upgrade
|
| Total Debt Repaid | - | -17.62 | -4.44 | -6.96 | -10.39 | Upgrade
|
| Net Debt Issued (Repaid) | - | -10.62 | -4.44 | -6.96 | -10.39 | Upgrade
|
| Issuance of Common Stock | - | - | 13.12 | 938.53 | - | Upgrade
|
| Repurchase of Common Stock | - | -33.78 | -18.47 | - | - | Upgrade
|
| Common Dividends Paid | - | -98.9 | -82.22 | -50 | -0.03 | Upgrade
|
| Other Financing Activities | - | -21.22 | 8.32 | -18.22 | -7.14 | Upgrade
|
| Financing Cash Flow | - | -164.52 | -83.69 | 863.34 | -17.57 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 0.02 | 0.01 | 0.01 | - | Upgrade
|
| Net Cash Flow | - | -550.07 | -184.21 | 903.71 | 122.3 | Upgrade
|
| Free Cash Flow | - | -7.2 | 61.76 | 72.41 | 134.01 | Upgrade
|
| Free Cash Flow Growth | - | - | -14.71% | -45.97% | 27.41% | Upgrade
|
| Free Cash Flow Margin | - | -1.70% | 18.12% | 19.21% | 39.23% | Upgrade
|
| Free Cash Flow Per Share | - | -0.07 | 0.62 | 0.87 | 1.79 | Upgrade
|
| Cash Income Tax Paid | - | 32.2 | 41.1 | 22.65 | 37.03 | Upgrade
|
| Levered Free Cash Flow | - | -41.98 | 24.83 | 21.54 | 76.5 | Upgrade
|
| Unlevered Free Cash Flow | - | -41.31 | 25.06 | 21.72 | 76.59 | Upgrade
|
| Change in Working Capital | - | -22.82 | 37.58 | -15.82 | 19.89 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.